Ronald Hillock, MD
Orthopaedic Surgery · Las Vegas, NVNPI 1073568903
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.0%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by UOC USA Inc at 54.9% of the total. Among orthopaedic surgery clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $828.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UOC USA Inc$151K
- Exactech, Inc.$30K
- Avanos Medical$28K
- Signature Orthopaedics USA Corp$22K
- Medical Device Business Services, Inc.$8K
- Johnson & Johnson$8K
- plus $28K from 37 others
Across 24 payments — averaging $6414.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exactech, Inc.$154K
What the payments were for
- Royalty or licence$61,54722%
- Consulting fees$131,88948%
- Speaking & faculty fees$31,55811%
- Travel & lodging$32,73412%
- Food & beverage$17,0496%
- Education$1370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- U-Star II$80,564
- USTAR II$30,976
- ON-Q$25,058
- OPTETRAK$17,405
- STRATAFIX$15,587
- Cones$11,040
- U2, Conformity, U-Motion II and USTAR II$10,912
- ALTEON$8,437
- U2$8,280
- SURGIFLO Hemostatic Matrix Family of Products$7,725
- DERMABOND Portfolio$7,725
- SURGICEL Family of Absorbable Hemostats$7,725
- HemoBlast Bellows$6,041
- N/A$5,040
- Long Nail DLT$4,206
- NOVATION HIP$3,840
- DLT Long Nail$3,464
- ON-Q* PUMP AND ACCESSORIES$2,394
- AOS PRODUCTS$1,911
- Irrisept$1,784
How this compares
$274,914 in reported general payments places this provider in the 95th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 112 | $11,371 |
| Ibuprofen | 19 | $154 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $97 |
| Naproxen | 13 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Las Vegas
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
- Galen KamLas Vegas$270K
- Michael DaubsLas Vegas$215K
- John BaldaufLas Vegas$117K
- Brian CarrLas Vegas$91K
- Brandon RomeroLas Vegas$72K
- Matthew BudgeLas Vegas$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.